AYTAÇ, S. A. Et Al. 2017. BONE MARROW MRD EVALUATION ON DAY 7 OF STEROID TREATMENT OF MODIFIED ST JUDE TOTAL XV THERAPY IN STANDART/LOW RISK PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA. 22nd Congress of the European-Hematology-Association , (Madrid, Spain), 352.

AYTAÇ, S. A., ÇETİN, M., Bajin, I. Y., Altan, I., ÜNAL, S., KUŞKONMAZ, B. B., ... Uckan, D.(2017). BONE MARROW MRD EVALUATION ON DAY 7 OF STEROID TREATMENT OF MODIFIED ST JUDE TOTAL XV THERAPY IN STANDART/LOW RISK PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA . 22nd Congress of the European-Hematology-Association (pp.352). Madrid, Spain

AYTAÇ, SAİT Et Al. "BONE MARROW MRD EVALUATION ON DAY 7 OF STEROID TREATMENT OF MODIFIED ST JUDE TOTAL XV THERAPY IN STANDART/LOW RISK PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA," 22nd Congress of the European-Hematology-Association, Madrid, Spain, 2017

AYTAÇ, SAİT A. Et Al. "BONE MARROW MRD EVALUATION ON DAY 7 OF STEROID TREATMENT OF MODIFIED ST JUDE TOTAL XV THERAPY IN STANDART/LOW RISK PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA." 22nd Congress of the European-Hematology-Association , Madrid, Spain, pp.352, 2017

AYTAÇ, S. A. Et Al. (2017) . "BONE MARROW MRD EVALUATION ON DAY 7 OF STEROID TREATMENT OF MODIFIED ST JUDE TOTAL XV THERAPY IN STANDART/LOW RISK PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA." 22nd Congress of the European-Hematology-Association , Madrid, Spain, p.352.

@conferencepaper{conferencepaper, author={SAİT AYKUT AYTAÇ Et Al. }, title={BONE MARROW MRD EVALUATION ON DAY 7 OF STEROID TREATMENT OF MODIFIED ST JUDE TOTAL XV THERAPY IN STANDART/LOW RISK PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA}, congress name={22nd Congress of the European-Hematology-Association}, city={Madrid}, country={Spain}, year={2017}, pages={352} }